Online citations, reference lists, and bibliographies.
← Back to Search

MR Imaging Radiomics Signatures For Predicting The Risk Of Breast Cancer Recurrence As Given By Research Versions Of MammaPrint, Oncotype DX, And PAM50 Gene Assays.

H. Li, Y. Zhu, E. Burnside, K. Drukker, Katherine A. Hoadley, C. Fan, S. Conzen, G. Whitman, E. Sutton, J. Net, M. Ganott, Erich P. Huang, E. Morris, C. M. Perou, Y. Ji, M. Giger
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Purpose To investigate relationships between computer-extracted breast magnetic resonance (MR) imaging phenotypes with multigene assays of MammaPrint, Oncotype DX, and PAM50 to assess the role of radiomics in evaluating the risk of breast cancer recurrence. Materials and Methods Analysis was conducted on an institutional review board-approved retrospective data set of 84 deidentified, multi-institutional breast MR examinations from the National Cancer Institute Cancer Imaging Archive, along with clinical, histopathologic, and genomic data from The Cancer Genome Atlas. The data set of biopsy-proven invasive breast cancers included 74 (88%) ductal, eight (10%) lobular, and two (2%) mixed cancers. Of these, 73 (87%) were estrogen receptor positive, 67 (80%) were progesterone receptor positive, and 19 (23%) were human epidermal growth factor receptor 2 positive. For each case, computerized radiomics of the MR images yielded computer-extracted tumor phenotypes of size, shape, margin morphology, enhancement texture, and kinetic assessment. Regression and receiver operating characteristic analysis were conducted to assess the predictive ability of the MR radiomics features relative to the multigene assay classifications. Results Multiple linear regression analyses demonstrated significant associations (R2 = 0.25-0.32, r = 0.5-0.56, P < .0001) between radiomics signatures and multigene assay recurrence scores. Important radiomics features included tumor size and enhancement texture, which indicated tumor heterogeneity. Use of radiomics in the task of distinguishing between good and poor prognosis yielded area under the receiver operating characteristic curve values of 0.88 (standard error, 0.05), 0.76 (standard error, 0.06), 0.68 (standard error, 0.08), and 0.55 (standard error, 0.09) for MammaPrint, Oncotype DX, PAM50 risk of relapse based on subtype, and PAM50 risk of relapse based on subtype and proliferation, respectively, with all but the latter showing statistical difference from chance. Conclusion Quantitative breast MR imaging radiomics shows promise for image-based phenotyping in assessing the risk of breast cancer recurrence. © RSNA, 2016 Online supplemental material is available for this article.
This paper references
10.1007/s10278-013-9622-7
The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
K. Clark (2013)
10.1056/NEJMOA052933
Concordance among gene-expression-based predictors for breast cancer.
C. Fan (2006)
10.1002/mrm.21347
Volumetric texture analysis of breast lesions on contrast‐enhanced magnetic resonance images
W. Chen (2007)
10.1002/9781118625590
Applied Regression Analysis: Draper/Applied Regression Analysis
N. Draper (1998)
10.1088/0031-9155/56/18/014
Computerized three-class classification of MRI-based prognostic markers for breast cancer.
N. Bhooshan (2011)
10.1097/00001622-199711000-00002
Recent advances in breast cancer biology
S. Domchek (1995)
10.1007/s10278-012-9452-z
Computerized Analysis of Mammographic Parenchymal Patterns on a Large Clinical Dataset of Full-Field Digital Mammograms: Robustness Study with Two High-Risk Datasets
Hui Li (2012)
10.1118/1.3013555
Anniversary paper: History and status of CAD and quantitative image analysis: the role of Medical Physics and AAPM.
M. Giger (2008)
10.1038/nature11412
Comprehensive molecular portraits of human breast tumors
D. Koboldt (2012)
10.1148/RADIOL.2252010845
Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.
Z. Huo (2002)
10.1186/s13058-014-0424-8
Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study
G. Gierach (2014)
10.1200/JCO.2008.18.1370
Supervised risk predictor of breast cancer based on intrinsic subtypes.
J. Parker (2009)
10.1148/radiol.14121031
Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.
S. Agner (2014)
10.1148/radiol.14131375
Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles.
A. Ashraf (2014)
10.2307/4615733
A Simple Sequentially Rejective Multiple Test Procedure
S. Holm (1979)
10.1016/S1076-6332(97)80121-3
The "proper" binormal model: parametric receiver operating characteristic curve estimation with degenerate data.
X. Pan (1997)
10.1007/s00330-012-2425-2
Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes
J. H. Youk (2012)
10.1148/radiol.09090838
Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.
N. Bhooshan (2010)
10.1373/CLINCHEM.2006.076497
Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer.
M. Cronin (2007)
10.1007/s10278-014-9710-3
The National Cancer Informatics Program (NCIP) Annotation and Image Markup (AIM) Foundation Model
Pattanasak Mongkolwat (2014)
10.1148/radiol.14132641
Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
M. Mazurowski (2014)
10.1007/978-3-642-45769-2_4
Experimental pathology and breast cancer genetics: new technologies.
P. Osin (1998)
10.1016/J.ACRA.2007.03.012
Reliable and computationally efficient maximum-likelihood estimation of "proper" binormal ROC curves.
L. Pesce (2007)
10.1016/j.ejrad.2014.03.014
A computerized global MR image feature analysis scheme to assist diagnosis of breast cancer: a preliminary assessment.
Q. Yang (2014)
10.1007/s10549-012-2143-0
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
A. Prat (2012)
10.1200/JCO.2005.04.7985
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
S. Paik (2006)
10.1146/annurev-bioeng-071812-152416
Breast image analysis for risk assessment, detection, diagnosis, and treatment of cancer.
M. Giger (2013)
10.1016/J.ACRA.2005.08.035
A Fuzzy C-Means (FCM)-Based Approach for Computerized Segmentation of Breast Lesions in Dynamic Contrast-Enhanced MR Images1
W. Chen (2006)
10.1118/1.598345
Computerized analysis of breast lesions in three dimensions using dynamic magnetic-resonance imaging.
K. G. Gilhuijs (1998)
10.1038/415530a
Gene expression profiling predicts clinical outcome of breast cancer
L. J. Veer (2002)
10.2217/fon.09.154
Update on the potential of computer-aided diagnosis for breast cancer.
M. Giger (2010)
10.1118/1.2210568
Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
W. Chen (2006)
10.1016/j.acra.2010.03.007
Computerized assessment of breast lesion malignancy using DCE-MRI robustness study on two independent clinical datasets from two manufacturers.
W. Chen (2010)
10.1056/NEJMOA021967
A gene-expression signature as a predictor of survival in breast cancer.
M. J. van de Vijver (2002)
10.1186/1755-8794-4-3
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures
C. Fan (2010)
10.1006/JMPS.1998.1218
"Proper" Binormal ROC Curves: Theory and Maximum-Likelihood Estimation.
Metz (1999)
10.1118/1.4865811
Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers.
H. Li (2014)
10.1118/1.1695652
Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics.
W. Chen (2004)
10.1056/NEJMOA041588
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
S. Paik (2004)



This paper is referenced by
10.1016/j.yacr.2019.04.012
Radiogenomics of Oncology: Current Trends and Future Directions
Jason Chiang (2019)
10.3389/fonc.2020.00888
Development of a Novel, Multi-Parametric, MRI-Based Radiomic Nomogram for Differentiating Between Clinically Significant and Insignificant Prostate Cancer
Yong-sheng Zhang (2020)
10.1002/jum.15294
Could Ultrasound‐Based Radiomics Noninvasively Predict Axillary Lymph Node Metastasis in Breast Cancer?
Xiaoying Qiu (2020)
10.1016/S1470-2045(20)30034-6
MRI-guided adaptive radiotherapy for liver tumours: visualising the future.
J. S. Witt (2020)
10.3390/diagnostics10060369
Impact of mRNA-Assessed Molecular Subtype Conversion, Intact and Apoptotic Circulating Tumor Cells on Survival of Metastatic Breast Cancer Patients: Proof of Principle
S. Stefanovic (2020)
10.1038/s41598-019-56767-3
Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network
R. Fukuma (2019)
Management of the Axilla in Breast Cancer - Routine Practice, Controversies and Outlook
Sidy Ka (2017)
10.1109/TBME.2020.2969839
Robust Collaborative Clustering of Subjects and Radiomic Features for Cancer Prognosis
Hangfan Liu (2020)
10.1007/978-3-319-42563-4_17
Personalized Medicine, Biomarkers of Risk and Breast MRI
E. Sutton (2017)
10.1016/j.acra.2017.03.006
Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions?
Elena Peña (2017)
10.17863/CAM.34779
Characterising heterogeneity of glioblastoma using multi-parametric magnetic resonance imaging
Chao Li (2018)
10.1002/jmri.26556
Role of texture analysis in breast MRI as a cancer biomarker: A review
Rhea D Chitalia (2019)
10.1007/s00261-019-02117-w
Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluation
Jennifer S Golia Pernicka (2019)
Quantitative Radiomic Analysis for Prognostic Medical Applications
C. Xu (2019)
10.1186/s13058-019-1199-8
Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients
Ming Fan (2019)
10.1007/s00330-019-06383-6
Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk
J. Y. Kim (2019)
10.1117/12.2255512
Identifying key radiogenomic associations between DCE-MRI and micro-RNA expressions for breast cancer
Ravi K. Samala (2017)
Dynamic radiomics: a new methodology to extract quantitative time-related features from tomographic images
Fengying Che (2020)
10.1038/s41598-018-37984-8
Combining Multiple Magnetic Resonance Imaging Sequences Provides Independent Reproducible Radiomics Features
A. Lecler (2019)
10.1007/978-3-030-59354-4_18
Multimodal Prediction of Breast Cancer Relapse Prior to Neoadjuvant Chemotherapy Treatment
S. Rabinovici-Cohen (2020)
10.2217/bmm-2020-0248
Cancer genotypes prediction and associations analysis from imaging phenotypes: a survey on radiogenomics.
Yao Wang (2020)
10.1007/s11307-019-01383-w
Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes
D. Leithner (2019)
10.1016/j.ejrad.2020.109066
Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
H. Chen (2020)
10.1038/s41598-019-40437-5
The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features
E. Limkin (2019)
10.1016/j.ijrobp.2018.08.032
A Deep Look Into the Future of Quantitative Imaging in Oncology: A Statement of Working Principles and Proposal for Change.
O. Morin (2018)
10.1186/s13058-018-1039-2
Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer
J. Wu (2018)
10.1016/j.ejrad.2017.11.007
Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Guang-yi Wang (2018)
10.1088/1361-6560/ab9f61
Standardization of CT radiomics features for multi-center analysis: impact of software settings and parameters.
Arianna Defeudis (2020)
10.1016/j.crad.2017.10.021
Clinical role of breast MRI now and going forward.
D. Leithner (2018)
10.23838/PFM.2017.00101
Radiomics and imaging genomics in precision medicine
G. Lee (2017)
10.3389/fnins.2019.00435
Correlation Between Hippocampus MRI Radiomic Features and Resting-State Intrahippocampal Functional Connectivity in Alzheimer’s Disease
Qi Feng (2019)
10.1007/s00330-019-06360-z
Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement
J. Park (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar